rs1800883 — HTR5A
Promoter/5' UTR variant in the serotonin 5-HT5A receptor gene affecting receptor expression, linked to schizophrenia susceptibility and executive function
Details
- Gene
- HTR5A
- Chromosome
- 7
- Risk allele
- G
- Consequence
- Regulatory
- Inheritance
- Additive
- Clinical
- Risk Factor
- Evidence
- Moderate
- Chip coverage
- v3 v4 v5
Population Frequency
Ancestry Frequencies
Category
Brain & Mental HealthSee your personal result for HTR5A
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
The Serotonin 5-HT5A Receptor — A Mysterious Link to Cognition and Mood
The serotonin system is one of the brain's most far-reaching neurotransmitter networks, and the 5-HT5A receptor11 5-HT5A receptor
One of 14 known serotonin receptor subtypes; 5-HT5A remains the least characterized encoded by HTR5A is among its most enigmatic members. Located on chromosome 7q36.1, HTR5A encodes a G-protein coupled receptor22 G-protein coupled receptor
A class of cell-surface receptors that transmit signals through intracellular G-proteins expressed primarily in the brain, particularly in the cerebral cortex, hippocampus, and cerebellum. The rs1800883 variant sits in the promoter/5' UTR region33 promoter/5' UTR region
The regulatory region upstream of the coding sequence that controls how much of the receptor protein is produced of the gene, in a CpG-rich area that may influence expression through epigenetic methylation.
The Mechanism
The rs1800883 polymorphism is located in the promoter region of the HTR5A gene within a region enriched in CpG repeats. While the exact functional consequence has not been fully elucidated, the CpG-rich context suggests the variant may alter gene expression through epigenetic mechanisms44 epigenetic mechanisms
Chemical modifications to DNA that affect gene activity without changing the sequence itself, particularly methylation of cytosine at CpG sites. The G allele, which is the more common allele globally (~61% frequency), has been associated with increased risk for psychiatric conditions. Changes in 5-HT5A receptor density or distribution in cortical and hippocampal regions could affect serotonergic signaling involved in cognition, mood regulation, and circadian rhythm modulation.
The 5-HT5A receptor signals primarily through inhibitory Gi/Go proteins, reducing cyclic AMP55 cyclic AMP
A key intracellular signaling molecule; reduced cAMP levels generally dampen neuronal activity production. It has been proposed to play a role in modulating exploratory behavior, mood, and memory consolidation, though its precise physiological functions remain under investigation compared to better-characterized serotonin receptors like 5-HT1A and 5-HT2A.
The Evidence
The strongest evidence for rs1800883 comes from a large Chinese Han case-control study66 large Chinese Han case-control study
Liu et al. Evaluation of association of common variants in HTR1A and HTR5A with schizophrenia and executive function. Scientific Reports 2016 that examined 1,115 schizophrenia patients and 2,289 controls in the discovery stage, with replication in 2,128 patients and 3,865 controls. The G allele was significantly associated with schizophrenia risk (discovery OR 1.21, 95% CI 1.09-1.34, P=0.000264; replication OR 1.13, 95% CI 1.05-1.22, corrected P=0.011). Importantly, the variant also showed significant interaction with executive function77 executive function
Higher-order cognitive abilities including planning, working memory, and cognitive flexibility, typically measured by the Wisconsin Card Sorting Test as measured by perseverative errors on the Wisconsin Card Sorting Test in patients but not in healthy controls.
An earlier case-control study in a Bulgarian population88 case-control study in a Bulgarian population
Grozeva et al. Case-control association study of 65 candidate genes. Journal of Affective Disorders 2009 screened 65 candidate genes across 172 bipolar disorder cases and 556 controls and found rs1800883 to be the most significant association (OR 1.80, 95% CI 1.27-2.54, corrected P=0.017). This cross-diagnostic association — spanning both schizophrenia and bipolar disorder — is consistent with the growing recognition that serotonin receptor variants can confer transdiagnostic psychiatric risk.
The evidence level is moderate: associations have been replicated in independent cohorts for schizophrenia, and the bipolar finding is preliminary. No GWAS meta-analyses have yet confirmed this locus at genome-wide significance for either condition.
Practical Implications
Because the functional consequence of this variant is not yet fully characterized, actionable recommendations must be cautious. The association with impaired executive function — specifically cognitive rigidity as measured by perseverative errors — suggests that G-allele carriers with psychiatric vulnerability may benefit from targeted cognitive training. The serotonergic mechanism also raises the question of whether 5-HT5A receptor variants modulate response to serotonergic medications, though no pharmacogenomic studies have addressed this directly.
Interactions
The 5-HT5A receptor's inhibitory signaling through Gi/Go proteins places it in a broader serotonergic network where other receptor variants (5-HT1A, 5-HT2A, 5-HT2C) and transporter variants (SLC6A4/5-HTTLPR) may modulate the overall serotonergic tone. The Liu et al. 2016 study also found significant associations for the 5-HT1A receptor variant rs878567 in the same cohort, raising the possibility of epistatic effects between multiple serotonin receptor variants on psychiatric risk and cognitive function. However, no formal gene-gene interaction analyses have been published for rs1800883 with other serotonin pathway variants.
Genotype Interpretations
What each possible genotype means for this variant:
Two copies of the minor allele — no increased psychiatric risk from this variant
You have two copies of the C allele at this position in the HTR5A gene promoter. This genotype is found in approximately 15% of people globally, with some variation by ancestry. The C allele was not associated with increased schizophrenia or bipolar disorder risk in the available studies. Your 5-HT5A receptor expression from this locus is expected to be typical.
One copy of the G allele — modestly increased serotonergic risk variant
You carry one copy of the G allele, which has been associated with a modest increase in schizophrenia susceptibility (OR ~1.13-1.21 per allele). This is the most common genotype, found in approximately 48% of people globally. One copy confers a small, population-level increase in risk that is not deterministic — most carriers never develop psychiatric conditions. The variant may subtly influence executive function through altered serotonin 5-HT5A receptor expression in prefrontal cortex and hippocampus.
Two copies of the G allele — highest serotonergic risk from this variant
You have two copies of the G allele, the most common allele at this locus. This genotype is found in approximately 37% of people globally. In genetic association studies, the G allele was associated with increased risk for both schizophrenia (OR 1.21 per allele in discovery) and bipolar disorder (OR 1.80 in a Bulgarian cohort). The homozygous GG genotype confers the highest per-variant risk, though the absolute risk increase remains modest. Executive function testing showed significant interaction with this variant in schizophrenia patients, with GG carriers making more perseverative errors on the Wisconsin Card Sorting Test.
Key References
First study associating rs1800883 with schizophrenia (OR 1.21, discovery n=3,404; replication n=5,993) and impaired executive function on WCST
Case-control study of 65 candidate genes finding rs1800883 associated with bipolar disorder in Bulgarian population (OR 1.80, P=0.000097)